Study to Assess the Safety of Amantadine Hydrochloride (HCl) Intravenous (IV) Solution (MR-301) in Patients With Severe Traumatic Brain Injury (TBI).
Condition(s):Traumatic Brain InjuryLast Updated:February 23, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Traumatic Brain InjuryLast Updated:February 23, 2024Not yet recruiting
Condition(s):Cardiovascular Risk; Acute Myocardial Infarction (AMI)Last Updated:February 2, 2024Not yet recruiting
Condition(s):Educational ActivitiesLast Updated:August 15, 2023Completed
Condition(s):Musculoskeletal PainLast Updated:March 6, 2024Completed
Condition(s):Heart FailureLast Updated:July 20, 2022Active, not recruiting
Condition(s):Diet Diversity; Infant NutritionLast Updated:April 13, 2021Unknown status
Condition(s):EpigeneticsLast Updated:February 15, 2023Suspended
Condition(s):ASCVDLast Updated:October 15, 2021Terminated
Condition(s):Aortic Valve Disease; Aortic Valve Stenosis; Aortic Valve FailureLast Updated:March 20, 2024Terminated
Condition(s):Pneumonia, Bacterial; Pneumonia, Viral; Pneumonia Fungal; Pneumonia Cavitary; Immunocompromised HostLast Updated:February 9, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.